Core Viewpoint - The 31st National Cancer Prevention and Control Publicity Week aims to promote cancer prevention knowledge and encourage healthy lifestyles to reduce cancer risk factors, particularly focusing on early screening and standardized treatment for cancer patients [1] Group 1: Cancer Statistics and Risk Factors - Lung cancer is the leading cause of cancer incidence and mortality in China, with 1.0606 million new cases and 733,300 deaths reported in 2022, accounting for 22.0% and 28.5% of all cancer cases and deaths respectively [2] - Approximately 80% to 90% of lung cancer cases are linked to smoking, with air pollution and occupational exposure also being significant risk factors [2][3] - High-risk groups for lung cancer include smokers, individuals over 45 years old, those with a history of chronic lung diseases, and people exposed to carcinogens like asbestos [4] Group 2: Screening and Early Detection - Chest CT screening is the primary method for early detection of lung cancer, with low-dose spiral CT significantly improving early detection rates [5] - Public awareness campaigns are essential to educate about lung cancer risk factors and symptoms, aiming to reduce unnecessary panic over lung nodules [3][5] - High-risk individuals should undergo regular screening to identify potential risks early [4] Group 3: Treatment Approaches - Lung cancer treatment is becoming more personalized, with a focus on comprehensive management to improve survival rates and quality of life [6] - Non-small cell lung cancer (NSCLC) accounts for over 80% of cases, with surgical resection being the standard treatment for early-stage patients, while advanced stages may require chemotherapy and targeted therapies [6][7] - Small cell lung cancer (SCLC) treatment often involves chemotherapy, with an emphasis on preventing metastasis [7] Group 4: Follow-Up Care - Regular follow-up is crucial for monitoring patient health and adjusting treatment strategies, with specific schedules based on cancer stage and treatment response [9][11] - Advanced monitoring techniques, such as ctDNA testing, are being integrated into follow-up care to detect recurrence earlier [10] - Follow-up frequency varies, with high-risk patients requiring more frequent assessments to ensure timely intervention [11]